195 related articles for article (PubMed ID: 15650541)
1. Thrombomodulin accelerates activated protein C production and inhibits thrombin generation in the plasma of disseminated intravascular coagulation patients.
Wada H; Sakakura M; Kushiya F; Nisikawa M; Onishi K; Nakatani K; Shiku H; Nobori T
Blood Coagul Fibrinolysis; 2005 Jan; 16(1):17-24. PubMed ID: 15650541
[TBL] [Abstract][Full Text] [Related]
2. Evidence that the protein C activation pathway amplifies the inhibition of thrombin generation by recombinant human thrombomodulin in plasma.
Ohishi R; Watanabe N; Aritomi M; Gomi K; Kiyota T; Yamamoto S; Ishida T; Maruyama I
Thromb Haemost; 1993 Sep; 70(3):423-6. PubMed ID: 8259542
[TBL] [Abstract][Full Text] [Related]
3. Protein C inhibitor acts as a procoagulant by inhibiting the thrombomodulin-induced activation of protein C in human plasma.
Elisen MG; von dem Borne PA; Bouma BN; Meijers JC
Blood; 1998 Mar; 91(5):1542-7. PubMed ID: 9473218
[TBL] [Abstract][Full Text] [Related]
4. Thrombomodulin alfa attenuates the procoagulant effect and cytotoxicity of extracellular histones through the promotion of protein C activation.
Osada K; Minami T; Arioka T; Sakai T; Tawara S; Kawasaki K; Fareed J; Matsuzaki O
Thromb Res; 2017 Dec; 160():51-57. PubMed ID: 29101790
[TBL] [Abstract][Full Text] [Related]
5. Protein C inhibitor regulates the thrombin-thrombomodulin complex in the up- and down regulation of TAFI activation.
Mosnier LO; Elisen MG; Bouma BN; Meijers JC
Thromb Haemost; 2001 Oct; 86(4):1057-64. PubMed ID: 11686324
[TBL] [Abstract][Full Text] [Related]
6. Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va.
Van Walderveen MC; Berry LR; Atkinson HM; Chan AK
Thromb Haemost; 2010 May; 103(5):910-9. PubMed ID: 20216984
[TBL] [Abstract][Full Text] [Related]
7. [Thrombomodulin].
Ohmori Y; Takahashi Y
Nihon Yakurigaku Zasshi; 2000 Nov; 116(5):283-9. PubMed ID: 11215378
[TBL] [Abstract][Full Text] [Related]
8. The impact of the endothelial protein C receptor on thrombin generation and clot lysis.
Pepler L; Wu C; Dwivedi DJ; Wu C; Kim PY; Liaw PC
Thromb Res; 2017 Apr; 152():30-37. PubMed ID: 28219843
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the role of thrombomodulin in all-trans retinoic acid treatment of coagulation disorders in cancer patients.
Ghaffari H; Varner JD; Petzold LR
Theor Biol Med Model; 2019 Feb; 16(1):3. PubMed ID: 30764845
[TBL] [Abstract][Full Text] [Related]
10. Increased anticoagulant activity of recombinant thrombomodulin modified with glycosaminoglycan.
Edano T; Inoue K; Yoshizaki H; Yamamoto S; Komine N; Tabunoki H; Sawada H; Koshi T; Murakami A; Wada Y; Ohkuchi M
Biol Pharm Bull; 1998 Apr; 21(4):375-81. PubMed ID: 9586576
[TBL] [Abstract][Full Text] [Related]
11. Decreased thrombomodulin mRNA expression on peripheral monocytes in disseminated intravascular coagulation patients relates to poor outcomes: the ex vivo effects of lipopolysaccharide and thrombin on monocyte thrombomodulin and CD14 mRNA.
Hong SK; Kim JE; Han KS; Kim HK
Thromb Res; 2013 Sep; 132(3):392-7. PubMed ID: 23954259
[TBL] [Abstract][Full Text] [Related]
12. Angiopoietins bind thrombomodulin and inhibit its function as a thrombin cofactor.
Daly C; Qian X; Castanaro C; Pasnikowski E; Jiang X; Thomson BR; Quaggin SE; Papadopoulos N; Wei Y; Rudge JS; Thurston G; Yancopoulos GD; Davis S
Sci Rep; 2018 Jan; 8(1):505. PubMed ID: 29323190
[TBL] [Abstract][Full Text] [Related]
13. Thrombomodulin/activated protein C system in septic disseminated intravascular coagulation.
Ikezoe T
J Intensive Care; 2015; 3(1):1. PubMed ID: 25705426
[TBL] [Abstract][Full Text] [Related]
14. Probing the activation of protein C by the thrombin-thrombomodulin complex using structural analysis, site-directed mutagenesis, and computer modeling.
Knobe KE; Berntsdotter A; Shen L; Morser J; Dahlbäck B; Villoutreix BO
Proteins; 1999 May; 35(2):218-34. PubMed ID: 10223294
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of recombinant soluble thrombomodulin in disseminated intravascular coagulation patients with renal impairment.
Hayakawa M; Yamamoto H; Honma T; Mukai N; Higashiyama A; Sugano M; Kubota N; Uegaki S; Sawamura A; Gando S
Shock; 2012 Jun; 37(6):569-73. PubMed ID: 22552020
[TBL] [Abstract][Full Text] [Related]
16. Relationship between disseminated intravascular coagulation and levels of plasma thrombinogen segment 1+2, D-dimer, and thrombomodulin in patients with multiple injuries.
Zhu YJ; Huang XK
Chin J Traumatol; 2009 Aug; 12(4):203-9. PubMed ID: 19635212
[TBL] [Abstract][Full Text] [Related]
17. Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex.
Rezaie AR; Cooper ST; Church FC; Esmon CT
J Biol Chem; 1995 Oct; 270(43):25336-9. PubMed ID: 7592694
[TBL] [Abstract][Full Text] [Related]
18. Thrombin cleaves recombinant soluble thrombomodulin into a lectin-like domain fragment and a fragment with protein C-activating cofactor activity.
Yokoyama H; Tateishi K; Baba Y; Kobayashi A; Hashimoto M; Fukuda S; Yamao H; Maruyama T; Nakata M; Matsushita M
Biosci Trends; 2022 Dec; 16(6):444-446. PubMed ID: 36450579
[TBL] [Abstract][Full Text] [Related]
19. Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation.
Ammollo CT; Semeraro F; Xu J; Esmon NL; Esmon CT
J Thromb Haemost; 2011 Sep; 9(9):1795-803. PubMed ID: 21711444
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological Differentiation of Thrombomodulin Alfa and Activated Protein C on Coagulation and Fibrinolysis In Vitro.
Tanaka K; Tawara S; Tsuruta K; Hoppensteadt D; Fareed J
Clin Appl Thromb Hemost; 2018 Sep; 24(6):859-866. PubMed ID: 29683037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]